{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T03:14:53Z","timestamp":1788146093387,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011392","name":"State Key Laboratory of Supramolecular Structure and Materials","doi-asserted-by":"publisher","award":["sklssm2024015"],"award-info":[{"award-number":["sklssm2024015"]}],"id":[{"id":"10.13039\/501100011392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2021 J02032"],"award-info":[{"award-number":["2021 J02032"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024 J01509"],"award-info":[{"award-number":["2024 J01509"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bioorg.2025.108551","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T10:41:41Z","timestamp":1746355301000},"page":"108551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A novel carbamate-based hybrid derivative with anti-neuroinflammatory properties as a selective butyrylcholinesterase inhibitor for Alzheimer's disease therapy"],"prefix":"10.1016","volume":"161","author":[{"given":"Xueyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiexin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoxian","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daijun","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zu-Cheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108551_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115297","article-title":"Targeting the multifaceted neurotoxicity of Alzheimer's disease by tailored functionalisation of the curcumin scaffold","volume":"252","author":"De Lorenzi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108551_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106663","article-title":"Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3beta inhibitors for Alzheimer's disease","volume":"138","author":"Yan","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108551_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116794","article-title":"Design, synthesis, and biological evaluation of imidazolylacetophenone oxime derivatives as novel brain-penetrant agents for Alzheimer's disease treatment","volume":"278","author":"Bian","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108551_bb0020","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.apsb.2023.10.015","article-title":"miR-429-3p mediates memory decline by targeting MKP-1 to reduce surface GluA1-containing AMPA receptors in a mouse model of Alzheimer's disease","volume":"14","author":"Luo","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.108551_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115817","article-title":"Targeting protein kinases for the treatment of Alzheimer's disease: Recent progress and future perspectives","volume":"261","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108551_bb0030","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1002\/alz.13089","article-title":"The Alzheimer's disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta-mediated pathology","volume":"19","author":"Samuels","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108551_bb0035","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1039\/D4MD00660G","article-title":"Pathogenesis of Alzheimer's disease and therapeutic strategies involving traditional Chinese medicine","volume":"15","author":"Li","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108551_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106595","article-title":"Interleukin-17 (IL-17) triggers systemic inflammation, peripheral vascular dysfunction, and related prothrombotic state in a mouse model of Alzheimer's disease","volume":"187","author":"Vellecco","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2025.108551_bb0045","doi-asserted-by":"crossref","unstructured":"J. Hu, Q. Chen, H. Zhu, L. Hou, W. Liu, Q. Yang, H. Shen, G. Chai, B. Zhang, S. Chen, Z. Cai, C. Wu, F. Hong, H. Li, S. Chen, N. Xiao, Z.X. Wang, X. Zhang, B. Wang, L. Zhang, W. Mo, Microglial Piezo1 senses Abeta fibril stiffness to restrict Alzheimer's disease, Neuron 111(1)(2022) 15-29 e8.","DOI":"10.1016\/j.neuron.2022.10.021"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108551_bb0050","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.apsb.2024.03.034","article-title":"Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease","volume":"14","author":"Barrera-Ocampo","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.108551_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116099","article-title":"Synthesis and evaluation of butylphthalide-scutellarein hybrids as multifunctional agents for the treatment of Alzheimer's disease","volume":"265","author":"Yu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108551_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116070","article-title":"Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities","volume":"265","author":"Zang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108551_bb0065","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.apsb.2022.01.017","article-title":"Celastrol enhances transcription factor EB (TFEB)-mediated autophagy and mitigates Tau pathology: Implications for Alzheimer's disease therapy","volume":"12","author":"Yang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.108551_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115670","article-title":"Discovery of triazole-bridged aryl adamantane analogs as an intriguing class of multifunctional agents for treatment of Alzheimer's disease","volume":"259","author":"Gutti","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108551_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116810","article-title":"Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease","volume":"279","author":"Zhao","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108551_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115803","article-title":"Galantamine-memantine hybrids for Alzheimer's disease: The influence of linker rigidity in biological activity and pharmacokinetic properties","volume":"261","author":"Basagni","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108551_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116450","article-title":"Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer's disease treatment","volume":"271","author":"Verma","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108551_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114606","article-title":"Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease","volume":"240","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108551_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115766","article-title":"Discovery of novel benzofuran-based derivatives as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease: Design, synthesis, biological evaluation, molecular docking and 3D-QSAR investigation","volume":"260","author":"Abd El-Karim","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108551_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116463","article-title":"Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's disease","volume":"272","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108551_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115253","article-title":"Development of the \u201chidden\u201d multi-target-directed ligands by AChE\/BuChE for the treatment of Alzheimer's disease","volume":"251","author":"Chen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108551_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116071","article-title":"Design, synthesis and biological evaluation of carbamate derivatives incorporating multifunctional carrier scaffolds as pseudo-irreversible cholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"265","author":"Liu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108551_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115832","article-title":"Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, \u03b2-secretase, and amyloid \u03b2 aggregation as potential treatment of Alzheimer's disease","volume":"261","author":"Zar\u0119ba","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108551_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106301","article-title":"The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators","volume":"131","author":"Chen","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108551_bb0125","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12974-023-02750-9","article-title":"Decrease in naturally occurring antibodies against epitopes of Alzheimer's disease (AD) risk gene products is associated with cognitive decline in AD","volume":"20","author":"Gu","year":"2023","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108551_bb0130","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s41467-023-37304-3","article-title":"An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer's disease","volume":"14","author":"Lau","year":"2023","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108551_bb0135","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.immuni.2022.07.004","article-title":"Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in aging and neurodegeneration","volume":"55","author":"Silvin","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.bioorg.2025.108551_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116409","article-title":"Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy","volume":"271","author":"Waiker","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108551_bb0145","doi-asserted-by":"crossref","first-page":"2313682","DOI":"10.1080\/14756366.2024.2313682","article-title":"Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer\u2019s disease","volume":"39","author":"Yu","year":"2024","journal-title":"J. Enzyme Inhibition Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108551_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2024.102190","article-title":"D30 Alleviates \u03b22-Microglobulin\u2013Facilitated Neurotoxic Microglial Responses in Isoflurane\/Surgery-Induced Cognitive Dysfunction in Aged Mice","volume":"105","author":"Chen","year":"2025","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bioorg.2025.108551_bb0155","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.4103\/NRR.NRR-D-23-01890","article-title":"The compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one alleviates neuroinflammation and cognitive impairment in a mouse model of Alzheimer\u2019s disease","volume":"20","author":"Liu","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bioorg.2025.108551_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123085","article-title":"Compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one downregulation of Galectin-3 ameliorates A\u03b2 pathogenesis-induced neuroinflammation in 5 \u00d7 FAD mice","volume":"357","author":"Liu","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2025.108551_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115120","article-title":"Novel neuroprotective pyromeconic acid derivatives with concurrent anti-A\u03b2 deposition, anti-inflammatory, and anti-oxidation properties for treatment of Alzheimer\u2019s disease","volume":"248","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108551_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117277","article-title":"Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer's disease","volume":"286","author":"Azam","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108551_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117066","article-title":"Discovery of novel hybrid tryptamine-rivastigmine molecules as potent AChE and BChE inhibitors exhibiting multifunctional properties for the management of Alzheimer's disease","volume":"283","author":"Shankar","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108551_bb0180","doi-asserted-by":"crossref","first-page":"2313682","DOI":"10.1080\/14756366.2024.2313682","article-title":"Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer's disease","volume":"39","author":"Yu","year":"2024","journal-title":"J. Enzyme Inhibition Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108551_bb0185","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.4103\/NRR.NRR-D-23-01890","article-title":"The compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one alleviates neuroinflammation and cognitive impairment in a mouse model of Alzheimer's disease","volume":"20","author":"Liu","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bioorg.2025.108551_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105013","article-title":"N-Propargylamine-hydroxypyridinone hybrids as multitarget agents for the treatment of Alzheimer\u2019s disease","volume":"113","author":"Guo","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108551_bb0195","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:27:18Z","timestamp":1762223238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825004316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":39,"alternative-id":["S0045206825004316"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108551","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel carbamate-based hybrid derivative with anti-neuroinflammatory properties as a selective butyrylcholinesterase inhibitor for Alzheimer's disease therapy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108551"}}